|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1998-8-13
|
|
pubmed:abstractText |
Thymoglobulin, a rabbit anti-human thymocyte globulin, was compared with Atgam, a horse anti-human thymocyte globulin for the treatment of acute rejection after renal transplantation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
pubmed-author:BasadonnaGG,
pubmed-author:BrennanD CDC,
pubmed-author:ChanLL,
pubmed-author:GIGLIMM,
pubmed-author:GaberA OAO,
pubmed-author:GaberL WLW,
pubmed-author:GastonR SRS,
pubmed-author:HamJ MJM,
pubmed-author:HodgeE EEE,
pubmed-author:KahanB DBD,
pubmed-author:KahanLL,
pubmed-author:KnechtleSS,
pubmed-author:LipisS MSM,
pubmed-author:MendezRR,
pubmed-author:MulrowR JRJ,
pubmed-author:NeylanJ FJF,
pubmed-author:NormanD JDJ,
pubmed-author:SchroederT JTJ,
pubmed-author:ShihabFF,
pubmed-author:SquiersEE,
pubmed-author:SteinbergSS,
pubmed-author:SteinerR WRW,
pubmed-author:TaylorR JRJ,
pubmed-author:TesiR JRJ,
pubmed-author:WoodleE SES
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
66
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
29-37
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9679818-Acute Disease,
pubmed-meshheading:9679818-Adolescent,
pubmed-meshheading:9679818-Adult,
pubmed-meshheading:9679818-Aged,
pubmed-meshheading:9679818-Animals,
pubmed-meshheading:9679818-Antilymphocyte Serum,
pubmed-meshheading:9679818-Double-Blind Method,
pubmed-meshheading:9679818-Female,
pubmed-meshheading:9679818-Graft Rejection,
pubmed-meshheading:9679818-Humans,
pubmed-meshheading:9679818-Immunosuppressive Agents,
pubmed-meshheading:9679818-Kidney Transplantation,
pubmed-meshheading:9679818-Male,
pubmed-meshheading:9679818-Middle Aged,
pubmed-meshheading:9679818-Rabbits
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.
|
|
pubmed:affiliation |
The University of Tennessee-Memphis, 38163, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|
